Align Technology wins FDA nod for Invisalign palatal expander system
December 18, 2023
Align Technology (Nasdaq:ALGN) announced today that the FDA granted 510(k) clearance for its Invisalign palatal expander system.
Align Technology (Nasdaq:ALGN) announced today that the FDA granted 510(k) clearance for its Invisalign palatal expander system.
William Blair analysts said the product “should revolutionize how glaucoma is treated by addressing noncompliance with drops.”
B. Braun Medical announced that it launched its new CareSite Micro luer access device designed to make IV access safer.
JVC today announced the commercial availability of its FDA-cleared, self-fitting, over-the-counter (OTC) hearing aids.
NuEyes announced today that the FDA granted approval to its patent-pending NuLoupes augmented reality smart glasses technology.
Glaukos (NYSE:GKOS) announced today that the FDA approved a New Drug Application (NDA) for its iDose TR implant.
The XpanTM Universal Trocar System is a first of its kind, radially expanding trocar that can be tailored by surgeons during laparoscopic procedures to accommodate 3 mm up to 12 mm instruments
The FDA has approved the Medtronic (NYSE: MDT)+
PulseSelect pulsed field ablation (PFA) system, the device developer said today.
The realistic model could aid the development of better heart implants and shed light on understudied heart disorders.
Neuranics announced today that it plans to launch a magnetic sensor development kit for monitoring the magnetic activity of the heart.